S&P 500   4,455.48
DOW   34,798.00
QQQ   373.33
S&P 500   4,455.48
DOW   34,798.00
QQQ   373.33
S&P 500   4,455.48
DOW   34,798.00
QQQ   373.33
S&P 500   4,455.48
DOW   34,798.00
QQQ   373.33

Proto Labs Stock Forecast, Price & News

-0.04 (-0.06 %)
(As of 09/24/2021 04:00 PM ET)
Today's Range
50-Day Range
52-Week Range
Volume189,673 shs
Average Volume466,932 shs
Market Capitalization$1.99 billion
P/E Ratio47.40
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive PRLB News and Ratings via Email

Sign-up to receive the latest news and ratings for Proto Labs and its competitors with MarketBeat's FREE daily newsletter.

Proto Labs logo

About Proto Labs

Proto Labs, Inc. engages in the digital manufacture of custom prototypes and production parts. It offers 3D printing, CNC machining, and injection molding services. The company was founded by Lawrence J. Lukis and Gregg Bloom on May 5, 1999 and is headquartered in Maple Plain, MN.


See More Headlines

Industry, Sector and Symbol

Sales & Book Value






Overall MarketRank

1.85 out of 5 stars

Industrial Products Sector

154th out of 240 stocks

Fabricated Structural Metal Products Industry

4th out of 6 stocks

Analyst Opinion: 3.1Community Rank: 4.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.9 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

Proto Labs (NYSE:PRLB) Frequently Asked Questions

Is Proto Labs a buy right now?

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Proto Labs in the last twelve months. There are currently 3 hold ratings and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" Proto Labs stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in PRLB, but not buy additional shares or sell existing shares.
View analyst ratings for Proto Labs
or view top-rated stocks.

What stocks does MarketBeat like better than Proto Labs?

Wall Street analysts have given Proto Labs a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Proto Labs wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Proto Labs' next earnings date?

Proto Labs is scheduled to release its next quarterly earnings announcement on Thursday, November 4th 2021.
View our earnings forecast for Proto Labs

How were Proto Labs' earnings last quarter?

Proto Labs, Inc. (NYSE:PRLB) issued its earnings results on Thursday, July, 29th. The industrial products company reported $0.39 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.31 by $0.08. The industrial products company earned $123.05 million during the quarter, compared to the consensus estimate of $121.95 million. Proto Labs had a trailing twelve-month return on equity of 5.61% and a net margin of 9.05%.
View Proto Labs' earnings history

How has Proto Labs' stock been impacted by COVID-19?

Proto Labs' stock was trading at $78.36 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, PRLB shares have decreased by 8.7% and is now trading at $71.58.
View which stocks have been most impacted by COVID-19

What guidance has Proto Labs issued on next quarter's earnings?

Proto Labs updated its third quarter 2021 earnings guidance on Friday, August, 6th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $123 million-$133 million, compared to the consensus revenue estimate of $125.58 million.

What price target have analysts set for PRLB?

4 brokerages have issued twelve-month price objectives for Proto Labs' shares. Their forecasts range from $90.00 to $135.00. On average, they expect Proto Labs' stock price to reach $112.50 in the next year. This suggests a possible upside of 57.2% from the stock's current price.
View analysts' price targets for Proto Labs
or view top-rated stocks among Wall Street analysts.

Who are Proto Labs' key executives?

Proto Labs' management team includes the following people:
  • Robert Bodor, President, Chief Executive Officer & Director
  • John A. Way, Chief Financial Officer & Executive VP-Development
  • Arthur Richard Baker, Chief Technology Officer
  • Bjoern Klaas, VP, Managing Director-Europe, Middle East & Africa
  • David M. Fein, Chief Revenue Officer

What is Victoria Holt's approval rating as Proto Labs' CEO?

90 employees have rated Proto Labs CEO Victoria Holt on Glassdoor.com. Victoria Holt has an approval rating of 97% among Proto Labs' employees. This puts Victoria Holt in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Proto Labs own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Proto Labs investors own include NVIDIA (NVDA), Tesla (TSLA), Brainstorm Cell Therapeutics (BCLI), Netflix (NFLX), Gilead Sciences (GILD), QUALCOMM (QCOM), Xilinx (XLNX), Advanced Micro Devices (AMD), The Walt Disney (DIS) and Square (SQ).

What is Proto Labs' stock symbol?

Proto Labs trades on the New York Stock Exchange (NYSE) under the ticker symbol "PRLB."

Who are Proto Labs' major shareholders?

Proto Labs' stock is owned by a number of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (16.16%), ARK Investment Management LLC (10.94%), Vanguard Group Inc. (10.45%), Brown Capital Management LLC (8.33%), Nikko Asset Management Americas Inc. (7.52%) and Sumitomo Mitsui Trust Holdings Inc. (7.54%). Company insiders that own Proto Labs stock include John B Goodman, Rainer Gawlick, Robert Bodor, Sven Wehrwein and Victoria M Holt.
View institutional ownership trends for Proto Labs

Which institutional investors are selling Proto Labs stock?

PRLB stock was sold by a variety of institutional investors in the last quarter, including Brown Capital Management LLC, ARK Investment Management LLC, Dimensional Fund Advisors LP, New York State Common Retirement Fund, Millennium Management LLC, Group One Trading L.P., Bank of America Corp DE, and Legal & General Group Plc.
View insider buying and selling activity for Proto Labs
or view top insider-selling stocks.

Which institutional investors are buying Proto Labs stock?

PRLB stock was purchased by a variety of institutional investors in the last quarter, including Disciplined Growth Investors Inc. MN, TimesSquare Capital Management LLC, Goldman Sachs Group Inc., Sumitomo Mitsui Trust Holdings Inc., Morgan Stanley, Morgan Stanley, Nikko Asset Management Americas Inc., and Healthcare of Ontario Pension Plan Trust Fund.
View insider buying and selling activity for Proto Labs
or or view top insider-buying stocks.

How do I buy shares of Proto Labs?

Shares of PRLB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Proto Labs' stock price today?

One share of PRLB stock can currently be purchased for approximately $71.58.

How much money does Proto Labs make?

Proto Labs has a market capitalization of $1.99 billion and generates $434.39 million in revenue each year. The industrial products company earns $50.87 million in net income (profit) each year or $1.89 on an earnings per share basis.

How many employees does Proto Labs have?

Proto Labs employs 2,408 workers across the globe.

What is Proto Labs' official website?

The official website for Proto Labs is www.protolabs.com.

Where are Proto Labs' headquarters?

Proto Labs is headquartered at 5540 Pioneer Creek Drive, Maple Plain MN, 55359.

How can I contact Proto Labs?

Proto Labs' mailing address is 5540 Pioneer Creek Drive, Maple Plain MN, 55359. The industrial products company can be reached via phone at (763) 479-3680 or via email at [email protected].

This page was last updated on 9/26/2021 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.